Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Corro Ramos

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2022
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression AnalysisHeleen Vellekoop, Matthijs Versteegh, Simone Huygens, et al.
Pharmacoeconomics|December 15, 2018
Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology AppraisalFrederick W Thielen, Nasuh C Büyükkaramikli, Rob Riemsma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2025
The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The NetherlandsBart-Jan Boverhof, Isaac Corro Ramos, Koen A Vermeer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic GuidelinesIsaac Corro Ramos, Matthijs M Versteegh, Rudolf A de Boer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 27, 2020
Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patientsSimone A Huygens, Isaac Corro Ramos, Carlijn V C Bouten, et al.
The Annals of Thoracic Surgery|January 4, 2019
What Is the Potential of Tissue-Engineered Pulmonary Valves in Children?Simone A Huygens, Maureen P M H Rutten-van Mölken, Anahita Noruzi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 22, 2020
Cost-utility analysis of four common surgical treatment pathways for breast cancerCasimir A E Kouwenberg, Marc A M Mureau, Leonieke W Kranenburg, et al.
Frontiers in Neurology|February 11, 2020
Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE)Valérie Wester, Saskia de Groot, Tim Kanters, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2022
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression AnalysisHeleen Vellekoop, Matthijs Versteegh, Simone Huygens, et al.
Pharmacoeconomics|December 15, 2018
Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology AppraisalFrederick W Thielen, Nasuh C Büyükkaramikli, Rob Riemsma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2025
The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The NetherlandsBart-Jan Boverhof, Isaac Corro Ramos, Koen A Vermeer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic GuidelinesIsaac Corro Ramos, Matthijs M Versteegh, Rudolf A de Boer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 27, 2020
Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patientsSimone A Huygens, Isaac Corro Ramos, Carlijn V C Bouten, et al.
The Annals of Thoracic Surgery|January 4, 2019
What Is the Potential of Tissue-Engineered Pulmonary Valves in Children?Simone A Huygens, Maureen P M H Rutten-van Mölken, Anahita Noruzi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 22, 2020
Cost-utility analysis of four common surgical treatment pathways for breast cancerCasimir A E Kouwenberg, Marc A M Mureau, Leonieke W Kranenburg, et al.
Frontiers in Neurology|February 11, 2020
Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE)Valérie Wester, Saskia de Groot, Tim Kanters, et al.
Pageof 4